Inpatient and Outpatient Orderable

Parvovirus B19, Molecular Detection, Quantitative, Amniotic Fluid

Synonyms

Erythema Infectiosum
Fifth disease
LAB11215
PARVOPCRAM
PARVOVIRUS B19 PCR, AF

Cerner Name

Clinical Info

Parvovirus B19 manifests itself as an acute or chronic hematological disorde
r in immunocompromised patients. It can cause persistent anemia, sometimes
associated with leukopenia and thrombocytopenia. Pediatric transplant patients
are at risk for chronic infections, which can be associated with lung and/or renal
disorders. Quantitative DNA PCR can be used to detect the presence of the
virus, track the course of infection, and monitor response to treatment.

Specimen Sources

Amniotic Sac

Specimen Types

Body Fluid

Container

Sterile

Collection Instructions

Container/Tube;: Sterile Screw Top Tubes
Specimen: 2 mL amniotic Fluid (0.5 mL min)
Transport Temperature: Room Temperature

Specimen Volume

Transport Instructions

Specimen Stability

4 Days Room Temperature

Methodology

Real-Time PCR Quantitative

Days Performed

TAT; 2 - 3 Days

Performing Laboratory

Viracor-Eurofins

CPT

87799

PDM

225036

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
PARVOVIRUS B19 QPCR	PARVOB19PCR	PARVOVIRUS B19 QPCR	Parvovirus B19 qPCR

Result Interpretation

See Report

Forms

Prenatal Cytogenetics Requisition

LAB11215

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });